Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: Implications for malaria treatment policy

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Ezenduka, Charles C ^a   Ogbonna, Brian O ^a   Ekwunife, Obinna I ^a   Okonta, Mathew J ^b   Esimone, Charles O ^a  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Affordable Medicines Facility malaria; Anti malarial drugs; Artemisinin based combination therapy; Private retail sector; Utilization pattern

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; HALOFANTRINE; MEPACRINE; PROGUANIL; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; VITAMIN; ARTEMISIN; DRUG COMBINATION; LACTONE;

ADOLESCENT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DRUG COST; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL DOCUMENTATION; MONOTHERAPY; NIGERIA; PATENT MEDICINE VENDOR; PHARMACY; PLASMODIUM FALCIPARUM; PRESCRIPTION; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; SELF CARE; SELF MEDICATION; URBAN AREA; ADULT; AGED; DRUG COMBINATION; INFANT; MIDDLE AGED; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD; URBAN POPULATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; LACTONES; MALARIA; MALE; MIDDLE AGED; NIGERIA; PHARMACIES; PROSPECTIVE STUDIES; URBAN POPULATION; YOUNG ADULT;

EID: 84903982991     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-243     Document Type: Article

References (35)

1. Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania. Hetzel MW, Dillip A, Lengeler C, Obrist B, Msechu JJ, Makemba AM, Mshana C, Schulze A, Mshinda H, BMC Public Health 2008 8 157 10.1186/1471-2458-8-157 18471299
2. Treatment of uncomplicated malaria at public health facilities and medicine retailers in southeastern Nigeria. Mangham LJ, Cundill B, Ezeoke O, Nwala E, Uzochukwu C, Wiseman V, Onwujekwe O, Malar J 2011 10 155 10.1186/1475-2875-10-155 21651787
3. An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community. Okeke TA, Uzochukwu BS, Okafor HU, Malar J 2006 5 97 10.1186/1475-2875-5-97 17078875
4. Antimalarial drug prescribing practice in private and public health facilities in south-east Nigeria: a descriptive study. Meremikwu M, Okomo U, Nwachukwu C, Oyo-Ita A, Eke-Njoku J, Okebe J, Oyo-Ita E, Garner P, Malar J 2007 6 55 10.1186/1475-2875-6-55 17480216
5. Malaria treatment perceptions, practices and influences on provider behaviour: comparing hospitals and non-hospitals in south-east Nigeria. Onwujekwe O, Uzochukwu B, Dike N, Uguru N, Nwobi E, Shu E, Malar J 2009 8 246 10.1186/1475-2875-8-246 19863803
6. Examining appropriate diagnosis and treatment of malaria: availability and use of rapid diagnostic tests and artemisinin-based combination therapy in public and private health facilities in south east Nigeria. Uzochukwu BS, Chiegboka LO, Enwereuzo C, Nwosu U, Okoroafor D, Onwujekwe OE, Uguru NP, Sibeudu FT, Ezeoke OP, BMC Public Health 2010 10 486 10.1186/1471-2458-10-486 20712876
7. Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: Implications for private medicine retailer interventions. Abuya TO, Mutemi W, Karisa B, Ochola SA, Fegan G, Marsh V, Malar J 2007 6 57 10.1186/1475-2875-6-57 17493270
8. Survey of antimalarial drugs prices and availability in retail outlets in Enugu urban South East Nigeria. Ezenduka CC, Okonta J, Ogbonna BO, Value Health 2013 16 96 doi:10.1016/j.jval.2013.03.451
9. Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets. Chuma J, Abuya T, Memusi D, Juma E, Akhwale W, Ntwiga J, Nyadigisi A, Tetter G, Shetta R, Amin A, Malar J 2009 8 243 10.1186/1475-2875-8-243 19863788
10. Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1countries. Davis B, Ladner J, Sams K, Tekinturhan E, de Korte D, Saba J, Malar J 2013 12 135 10.1186/1475-2875-12-135 23607504
11. WHO, WHO guidelines for treatment of malaria Geneva: World Health Organization WHO/HTM/MAL/2006.1108
12. Hanson K, Goodman C, Lines J, Meek S, Bradley D, Mills A, The Economics of Malaria Control Interventions Geneva: Global Forum for Health Research 2004
13. Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya. Zurovac D, Rowe AK, Ochola SA, Noor AM, Midia B, English M, Snow RW, Int J Epidemiol 2004 33 1080 1091 10.1093/ije/dyh253 15256523
14. Retail supply of malaria-related drugs in rural Tanzania; risks and opportunities. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P, Trop Med Int Health 2004 9 655 663 10.1111/j.1365-3156. 2004.01245.x 15189455
15. Where do people from different socio-economic groups receive diagnosis and treatment for presumptive malaria in south-east Nigeria? Onwujekwe O, Ojukwu J, Uzochukwu B, Dike N, Ikeme A, Shu E, Ann Trop Med Parasitol 2005 99 473 481 10.1179/136485905X51283 16004706
16. Federal Republic of Nigeria, National Antimalarial Treatment Policy Abuja, Nigeria 2005
17. Enugu State Ministry of Health, Malaria Control Activities Report 2007
18. The economic burden of malaria on households and the health system in Enugu State Southeast Nigeria. Onwujekwe O, Uguru N, Etiaba E, Chikezie I, Uzochukwu B, Adjagba A, PLoS One 2013 8 78362 10.1371/journal.pone.0078362 24223796
19. Self-treatment for malaria: the evidence and methodological issues. McCombie SC, Health Policy Plan 2002 17 333 344 10.1093/heapol/17.4.333 12424205
20. Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda. Sears D, Kigozi R, Mpimbanza A, Kakeeto S, Sserwanga A, Staedike SG, Chang M, Kapella BK, Rubahika D, Kamya MR, Dosey G, Malar J 2013 12 252 10.1186/1475-2875-12-252 23870515
21. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin- combination therapy. Dodoo ANP, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D, Malar J 2009 8 2 10.1186/1475-2875-8-2 19123926
22. Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. Schramm B, Valeh P, Baudin E, Mazinda ES, Smith R, Pinoges L, Sundaygar T, Zolia YM, Jones JJ, Comte E, Brunee A, Branger M, Jullien V, Carn G, Kiechel J, Guérin PJ, Malar J 2013 12 250 10.1186/1475-2875-12-250 23866736
23. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Faye B, Offianan AT, Ndiaye JL, Tine RC, Toure W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O, Trop Med Int Health 2010 15 608 613 20214761
24. Management of malaria by medicine retailers in a Nigerian urban community. Erhun WO, Osagie A, J Health Popul Dev Countries 2004 [ http://www.jhpdc.unc.edu/ ]
25. Knowledge and behaviour as determinants of anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya. Watsierah CA, Jura WG, Raballah E, Kaseje D, Abong'o B, Ouma C, Malar J 2011 10 99 10.1186/1475-2875-10-99 21507227
26. Overlap in the clinical features of pneumonia and malaria in African children. O'Dempsey TJ, McArdle TF, Laurence BE, Lamont AC, Todd JE, Greenwood BM, Trans R Soc Trop Med Hyg 1993 87 662 665 10.1016/0035-9203(93)90279-Y 8296367
27. Malaria misdiagnosis: effects on the poor and vulnerable. Amexo M, Tolhurst R, Barnish G, Bates I, Lancet 2004 364 1896 1898 10.1016/S0140-6736(04) 17446-1 15555670
28. Improving malaria home treatment by training drug retailers in rural Kenya. Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, Marsh K, Trop Med Int Health 2004 9 451 460 10.1111/j.1365-3156.2004.01223.x 15078263
29. Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya. Tavrow P, Shabahang J, Makama S, Malar J 2003 2 10 10.1186/1475-2875-2-10 12812525
30. Using a holistic approach to transform private sector drug outlets: the Tanzania experience. Presentation to the strategies for enhancing access to medicines conference, Accra, Ghana, June 20-22. Mbwasi R, 2005 [ http://www.msh.org/seam/conference2005/pdf/Day1/07-Tr01-Mbwasi-pres.pdf ]
31. Do poor people use poor quality providers? Evidence from the treatment of presumptive malaria in Nigeria. Onwujekwe O, Hanson K, Uzochukwu B, Trop Med Int Health 2011 16 1087 1098 10.1111/j.1365-3156.2011.02821.x 21702870
32. Activated oxygen mediates the antimalarial activity of qinghaosu. Meshnick SR, Tsang TW, Lin FB, Pan HZ, Chang CN, Kuypers F, Chiu D, Lubin B, Prog Clin Biol Res 1989 313 95 104 2675120
33. Interactions between retinol and some established antimalarials in Plasmodium nigeriensis infection in mice. Oreagba AI, Ashorobi RB, Int J Pharmacol 2007 3 270 274
34. A study of the effect of ascorbic acid on the antiplasmodial activity of artemether in Plasmodium berghei infected mice. Ganiyu KA, Akinleye MO, Tayo F, J Appl Pharm Sci 2012 2 96 100
35. The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. Reyburn H, Ruanda J, Mwerinde O, Drakeley C, Malar J 2006 5 4 10.1186/1475-2875-5-4 16423307